Optra-S™

Therapeutic Segment:

Anti-Asthmatic & COPD

Generic Name:

Ipratropium Bromide + Salbutamol

Indication

Nebuliser Solution - Unit Dose Vial (UDV)
  • 0.5mg + 2.5mg/2.5ml

Optra-S (Ipratropium Bromide + Salbutamol) Nebuliser Solution is indicated for the:

  • Symptomatic treatment of bronchospasm in adults and adolescents over 12 years of age with chronic obstructive pulmonary disease who require treatment with both Ipratropium Bromide and Salbutamol.